Liver Transplant
114
25
29
48
Key Insights
Highlights
Success Rate
86% trial completion
Published Results
19 trials with published results (17%)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
7.0%
8 terminated out of 114 trials
85.7%
-0.8% vs benchmark
12%
14 trials in Phase 3/4
40%
19 of 48 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 48 completed trials
Clinical Trials (114)
Liver Transplantation With Tregs at MGH
Expanding Liver Transplant Immunosuppression Minimization Via Everolimus
The Use of Hepatitis C Positive Livers in Hepatitis C Negative Liver Transplant Recipients
Early Signals of the Transition From Immune Quiescence to Activation in the Liver Allograft Microenvironment and in the Circulation
Efficacy and Safety of Everolimus Versus Mycophenolate Mofetil in Liver Transplant Recipients.
Effect of Preoperative Oral Carbohydrate Loading on Postoperative Outcomes in Liver Transplant Patients
Cytomegalovirus (CMV) Vaccine in Orthotopic Liver Transplant Candidates
Multicenter Study on Organ Acquisition Costs in the Post Re-Allocation Era: Liver Transplantation
Safety of Atezolizumab-Bevacizumab in Liver Transplanted Patients With Advanced Hepatocellular Carcinoma
Transitional ePRO Diary Liver (Transitional-ePRO)
Trial of Inhaled Nitric Oxide (iNO) on Ischemia / Reperfusion Injury During Orthotopic Liver Transplantation With Marginal Grafts
EVR and EPO for Liver Transplant Tolerance
Targeting Trimethylamine N-Oxide for Cardiovascular Health In Liver Transplant Recipients
Auriculo-Nerve Stimulation on Post-Operative Opioid Requirement
Feasibility and Acceptability of a New Tool Promoting a Healthy Lifestyle in Liver and Kidney Transplant Recipients
Renal Histopathology and Transcriptomic Analysis in Hepatorenal Syndrome During Liver Transplantation
Long-term Follow-up of the Offspring Born to Mothers With a Solid Organ Transplant, Transplantlines Next Generation
A Prospective Study to Evaluate the Efficacy and Safety of Entecavir ODT Conversion in Stable Liver Transplant Patients
Cabozantinib to Treat Recurrent Liver Cancer Post Transplant
Liver Transplant CGM